Især i tilfælde af større kirurgiske indgreb er omhyggelig overvågning af substitutionsterapien – vha. koaguleringsanalyser (faktor IX- aktivitet i plasmet) – ufravigelig.
In the case of major surgical interventions in particular, precise monitoring of substitution therapy by means of coagulation analysis (plasma factor IX activity) is indispensable.